Safety of Besivance™ (Besifloxacin Ophthalmic Suspension) 0.6% Compared to Vehicle

Clinical trial NCT01175590 · COMPLETED

Trial details

NCT number: NCT01175590
Sponsor: Bausch & Lomb Incorporated
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Conjunctivitis

Start date: 2010-06-01
Primary completion: 2011-12-01
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.